SEC Filing Summary: Xenomics, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Xenomics, Inc. on July 26, 2006, covering events occurring on July 20, 2006. The registrant is incorporated in Florida with principal executive offices in New York, New York. The filing discloses unregistered sales of equity securities.
Key Financial Metrics and Transaction Details
The filing details a specific capital raise transaction rather than periodic financial performance metrics such as revenue or operating margins.
- Securities Sold: 640,000 shares of common stock and 320,000 warrants to purchase common stock.
- Investor: A single overseas investor.
- Gross Proceeds: $800,000.
- Warrant Terms: Exercisable at $2.00 per share for a term of three years from issuance.
- Transaction Costs: $80,000 paid in selling commissions to a selling agent.
- Agent Compensation: 83,200 additional warrants issued to the selling agent.
Material Changes and Regulatory Basis
The transaction represents a discrete capital event. The Company relied on the exemption from registration provided by Regulation S under the Securities Act of 1934 for the offer and sale of securities to the overseas investor. No comparative financial data or material changes to prior periods are provided in this specific filing.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the unregistered sale. The primary focus is the execution of the securities purchase agreement and the issuance of warrants.
Key Facts for Investor Verification
- Verify the use of proceeds from the $800,000 gross capital raise.
- Confirm the dilution impact of the 640,000 new shares and the 403,200 total warrants issued (320,000 to investor + 83,200 to agent).
- Review the full Securities Purchase Agreement (Exhibit 10.1) for covenants or restrictions.
- Check subsequent filings for the exercise status of the warrants issued at the $2.00 strike price.